ZYNE Forecast and Technical Stock Analysis
Sell candidate since 2019-10-04 Loss -0.91% PDF
Zynerba Pharmaceuticals gained 1.87% in the last trading day ( Monday, 14th Oct 2019 ), rising from $7.49 to $7.63 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 5.98% from a day low at $7.36 to a day high of $7.80. The price has been going up and down for this period, and there has been a 0.93% gain for the last 2 weeks. Volume fell in the last day by -229 958 shares and in total, 288 754 shares bought and sold for approximately $2.20 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the ZYNE stock price was $12.22 and low was $6.83.
- 90 day high was $14.15 and low was $6.83.
- 52 week high for Zynerba Pharmaceuticals - $16.46 and low - $2.75.
Zynerba Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -29.22% during the next 3 months and, with 90% probability hold a price between $4.55 and $7.53 at the end of this period.
Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Zynerba Pharmaceuticals holds a buy signal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $9.41. On a fall, the stock will find some support from the short-term average at $7.62. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Thursday October 03, 2019, which indicates further falls until a new bottom pivot has been found.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 48 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Zynerba Pharmaceuticals finds support from accumulated volume at $7.60.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.44 between high and low, or 5.98%. For the last week, the stock has had a daily average volatility of 5.47%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
5.47 %Average volatility
Very Low Low Medium High Very High
|ZYNE $7.63 ($0.14 1.87%)|
ZYNE is up $0.14 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ZYNE based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ZYNE analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!